Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.

Aberrant crypt foci (ACF) in colorectal mucosa are proposed to be the earliest morphological lesion in the development of neoplasia, but their characteristics remain controversial. We therefore studied the epithelial phenotype and genotype of ACF from patients with familial adenomatous polyposis (FAP) and of sporadic ACF by evaluating glycoprotein markers associated with neoplasia (lectins Dolichus biflorus agglutinin and peanut agglutinin; monoclonal antibody CA 19-9 against sialyl Lewis-a blood group substance), expression of proliferating cell nuclear antigen, and ras proto-oncogene mutations. The utility of the markers was established by comparing adenomas and hyperplastic polyps. Most FAP ACF resembled adenomas and were found to differ from sporadic ACF in their high frequency of dysplasia, staining with Dolichus biflorus agglutinin, expression of sialyl Lewis-a, proliferation in the epithelium of upper crypts, and low frequency of ras gene mutations (P = .04 to < .0000001). By contrast, sporadic ACF and a subset of FAP ACF had phenotypic characteristics resembling hyperplastic polyps but usually had ras mutations, which were inversely related to dysplasia (P = .00009). Our findings suggest that "aberrant crypt focus" is a generic term analogous to "polyp" and requires further histopathologic, phenotypic, or genotypic classification into dysplastic and heteroplastic (hetero = other, plasia = form) types. Dysplastic ACF represent potential precursors to colorectal adenomas and adenocarcinomas, but heteroplastic ACF appear to be associated, rather than precursor, lesions.

[1]  P. J. Young,et al.  Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. , 1992, Gut.

[2]  A. Schauer,et al.  Histochemical study of expression of lectin-reactive carbohydrate epitopes and glycoligand-binding sites in normal human appendix vermiformis, colonic mucosa, acute appendicitis and colonic adenoma. , 1996, Histology and histopathology.

[3]  B. Trump,et al.  Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue. , 1985, Cancer Research.

[4]  L. Roncucci,et al.  K‐ras AND p53 MUTATIONS IN HUMAN COLORECTAL ABERRANT CRYPT FOCI , 1996, The Journal of pathology.

[5]  F. dall’Olio,et al.  Protein glycosylation in cancer biology: an overview , 1996, Clinical molecular pathology.

[6]  M. Stolte,et al.  Colorectal Mini-De Novo Carcinoma: A Reality in Germany Too , 1995, Endoscopy.

[7]  M. Risio,et al.  Mucosal cell proliferation in patients with hyperplastic colorectal polyps. , 1995, Scandinavian journal of gastroenterology.

[8]  C. Boland,et al.  Regional differences in normal and cancer-associated glycoconjugates of the human colon. , 1985, Journal of the National Cancer Institute.

[9]  Christopher D. Heinen,et al.  Microsatellite instability in aberrant crypt foci from human colons. , 1996, Cancer research.

[10]  L. Roncucci,et al.  Identification and quantification of aberrant crypt foci and microadenomas in the human colon. , 1991, Human pathology.

[11]  K. Forde,et al.  Spatial clustering of multiple hyperplastic, adenomatous, and malignant colonic polyps in individual patients , 1989, Diseases of the colon and rectum.

[12]  T. Muto,et al.  Small “flat adenoma” of the large bowel with special reference to its clinicopathologic features , 1985, Diseases of the colon and rectum.

[13]  M. Tsuneyoshi,et al.  Depressed adenoma of the colorectum: Analysis of proliferative activity using immunohistochemical staining for proliferating cell nuclear antigen (PCNA) , 1994, Pathology international.

[14]  M. Kaminishi,et al.  Depressed adenoma in the large intestine , 1990, Diseases of the colon and rectum.

[15]  R P Bird,et al.  Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.

[16]  T. P. Pretlow,et al.  Carcinoembryonic antigen in human colonic aberrant crypt foci. , 1994, Gastroenterology.

[17]  S. Hamilton,et al.  The adenoma‐adenocarcinoma sequence in the large bowel: Variations on a theme , 1992, Journal of cellular biochemistry. Supplement.

[18]  K. Stȩpniewska,et al.  High frequency of K-ras mutations in sporadic colorectal adenomas. , 1993, Gut.

[19]  K. Kinzler,et al.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.

[20]  M. Ilyas,et al.  Genetic pathways in colorectal cancer , 1996, Histopathology.

[21]  J. C. Lee,et al.  Growth kinetics of colorectal adenoma-carcinoma sequence: an immunohistochemical study of proliferating cell nuclear antigen expression. , 1996, Human pathology.

[22]  A. Kinsella,et al.  K-ras gene mutations in adenomas and carcinomas of the colon. , 1992, Surgical oncology.

[23]  M. Fukayama,et al.  Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. , 1994, Cancer research.

[24]  I. Siu,et al.  Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. , 1996, Gastroenterology.

[25]  S. Hamilton Pathogenesis of polyps (adenomas) , 1983, Diseases of the colon and rectum.

[26]  E. Kaplan,et al.  K-ras mutations in putative preneoplastic lesions in human colon. , 1993, Journal of the National Cancer Institute.

[27]  H. Esumi,et al.  Frequent and characteristic K‐ras activation in aberrant crypt foci of colon. Is there preference among K‐ras mutants for malignant progression? , 1995, Cancer.

[28]  H. Bussey,et al.  Familial polyposis coli. , 1975, Pathology annual.

[29]  S. Gallinger,et al.  Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. , 1994, Cancer research.

[30]  E. Wiley,et al.  Distribution of blood group substances in normal human colon. Use of the unlabeled antibody (PAP) immunoperoxidase technic to identify A and B blood group substances. , 1981, American journal of clinical pathology.

[31]  D. Owen,et al.  Flat adenomas of the colon. , 1991, Human pathology.

[32]  E. Riecken,et al.  Alteration of mucin-bound carbohydrate moieties in malignant transformation of colonic mucosa , 1992 .

[33]  E. Campo,et al.  Lectin binding patterns in normal and neoplastic colonic mucosa , 1988, Diseases of the colon and rectum.

[34]  U Landegren,et al.  A ligase-mediated gene detection technique. , 1988, Science.

[35]  G. Yang,et al.  Gal-GalNAc: a biomarker of colon carcinogenesis. , 1996, Histology and histopathology.

[36]  T. Muto,et al.  Lower Incidence of K‐ras Codon 12 Mutation in Flat Colorectal Adenomas than in Polypoid Adenomas , 1994, Japanese journal of cancer research : Gann.

[37]  M. Fukuda Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.

[38]  T. P. Pretlow,et al.  Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen. , 1993, The American journal of pathology.

[39]  K. Kinzler,et al.  Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.

[40]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[41]  P. Quirke,et al.  p53 expression and K-ras mutation in colorectal adenomas. , 1993, Gut.

[42]  H. Esumi,et al.  Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. , 1995, Gastroenterology.

[43]  B. Trump,et al.  Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon. , 1981, Journal of the National Cancer Institute.

[44]  E. Deschner Experimentally induced cancer of the colon , 1974, Cancer.

[45]  N. Marcon,et al.  Mixed hyperplastic adenomatous polyps--an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. , 1984, The American journal of surgical pathology.

[46]  H. Cooper,et al.  Peanut lectin binding sites in colons of patients with ulcerative colitis. , 1987, Archives of pathology & laboratory medicine.

[47]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[48]  C. Moskaluk,et al.  Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. , 1997, The American journal of pathology.

[49]  M. Herlyn,et al.  Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R Levine,et al.  Prevention and early detection of colorectal cancer. , 1992, American family physician.

[51]  A. Yanagisawa,et al.  Variation in K‐ras Codon 12 Point Mutation Rate with Histological Atypia within Individual Colorectal Tumors , 1993, Japanese journal of cancer research : Gann.

[52]  S. Kudo,et al.  The problem of de novo colorectal carcinoma. , 1995, European journal of cancer.

[53]  A. E. Szulman THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE , 1962, The Journal of experimental medicine.

[54]  L. Sobin,et al.  Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large intestine. , 1995, Journal of clinical pathology.

[55]  Fairman Mp DNA polymerase delta/PCNA: actions and interactions. , 1990 .

[56]  L. Roncucci,et al.  Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy). , 1993, Cancer research.

[57]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[58]  H. Cooper,et al.  Hyperplastic polyps of the colon and rectum. An immunohistochemical study with monoclonal antibodies against blood groups antigens (sialosyl-Lea, Leb, Lex, Ley, A, B, H). , 1987, Laboratory investigation; a journal of technical methods and pathology.

[59]  T. Sugimura,et al.  Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. , 1994, Cancer research.

[60]  A. Shamsuddin,et al.  Expression of carcinoembryonic antigen, T-antigen, and oncogene products as markers of neoplastic and preneoplastic colonic mucosa. , 1987, Human pathology.

[61]  G. Corner,et al.  Evidence for genomic instability in human colonic aberrant crypt foci. , 1996, Oncogene.

[62]  Masaki Kitajima,et al.  Expression of Sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma , 1995 .

[63]  P. Hall,et al.  The complexities of proliferating cell nuclear antigen , 1992, Histopathology.

[64]  K. Kinzler,et al.  Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. , 1996, The American journal of pathology.

[65]  K. Tanaka,et al.  Familial polyposis: recent advances. , 1995, Critical reviews in oncology/hematology.

[66]  C. Fenoglio-Preiser,et al.  Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas: A Distinct Form of Colorectal Neoplasia , 1990, The American journal of surgical pathology.

[67]  M. Kobayashi,et al.  Effect of K-ras mutation on morphogenesis of colorectal adenomas and early cancers: relationship to distribution of proliferating cells. , 1996, Human pathology.

[68]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[69]  John I. Allen,et al.  Molecular biology of colon polyps and colon cancer. , 1995, Seminars in surgical oncology.

[70]  H. Esumi,et al.  Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. , 1995, Cancer research.

[71]  V. Reuter,et al.  Peanut lectin-binding sites in polyps of the colon and rectum. Adenomas, hyperplastic polyps, and adenomas with in situ carcinoma. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[72]  R P Bird,et al.  Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. , 1995, Cancer letters.

[73]  A. E. Szulman THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE , 1964, The Journal of experimental medicine.

[74]  M. Melamed,et al.  Immunohistologic expression of blood‐group antigens in normal human gastrointestinal tract and colonic carcinoma , 1986, International journal of cancer.

[75]  J. Jass RELATION BETWEEN METAPLASTIC POLYP AND CARCINOMA OF THE COLORECTUM , 1983, The Lancet.

[76]  I. Kino,et al.  Depressed adenomas of the colon in familial adenomatous polyposis. Histology, immunohistochemical detection of proliferating cell nuclear antigen (PCNA), and analysis of the background mucosa. , 1995, American Journal of Surgical Pathology.

[77]  J. Jass,et al.  Sialic Acid and Epithelial Differentiation in Colorectal Polyps and Cancer – A Morphological, Mucin and Lectin Histochemical Study , 1992, Pathology.

[78]  C. Boland,et al.  Lectin reactivities as intermediate biomarkers in premalignant colorectal epithelium , 1992, Journal of cellular biochemistry. Supplement.